- Home
- DTST vs CALC Comparison
DTST vs CALC Comparison
Compare DTST & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- CALC
- Stock Information
- Founded
- DTST 2001
- CALC 2011
- Country
- DTST United States
- CALC United States
- Employees
- DTST N/A
- CALC N/A
- Industry
- DTST EDP Services
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- CALC Health Care
- Exchange
- DTST Nasdaq
- CALC Nasdaq
- Market Cap
- DTST 28.2M
- CALC 26.7M
- IPO Year
- DTST N/A
- CALC N/A
- Fundamental
- Price
- DTST $3.88
- CALC $1.74
- Analyst Decision
- DTST
- CALC Strong Buy
- Analyst Count
- DTST 0
- CALC 3
- Target Price
- DTST N/A
- CALC $16.33
- AVG Volume (30 Days)
- DTST 48.0K
- CALC 22.8K
- Earning Date
- DTST 05-15-2025
- CALC 05-14-2025
- Dividend Yield
- DTST N/A
- CALC N/A
- EPS Growth
- DTST N/A
- CALC N/A
- EPS
- DTST 0.02
- CALC N/A
- Revenue
- DTST $25,219,312.00
- CALC N/A
- Revenue This Year
- DTST $12.57
- CALC N/A
- Revenue Next Year
- DTST $9.29
- CALC N/A
- P/E Ratio
- DTST $160.15
- CALC N/A
- Revenue Growth
- DTST N/A
- CALC N/A
- 52 Week Low
- DTST $2.93
- CALC $1.43
- 52 Week High
- DTST $6.96
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- DTST 54.72
- CALC 47.92
- Support Level
- DTST $3.66
- CALC $1.61
- Resistance Level
- DTST $3.95
- CALC $1.73
- Average True Range (ATR)
- DTST 0.19
- CALC 0.10
- MACD
- DTST -0.01
- CALC -0.01
- Stochastic Oscillator
- DTST 54.90
- CALC 33.33
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.